These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11776485)

  • 1. Is an FDG-PET scan the new imaging standard for colon cancer?
    Swanson RS
    Ann Surg Oncol; 2001 Dec; 8(10):752-3. PubMed ID: 11776485
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels.
    Libutti SK; Alexander HR; Choyke P; Bartlett DL; Bacharach SL; Whatley M; Jousse F; Eckelman WC; Kranda K; Neumann RD; Carrasquillo JA
    Ann Surg Oncol; 2001 Dec; 8(10):779-86. PubMed ID: 11776491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
    Staib L; Schirrmeister H; Reske SN; Beger HG
    Am J Surg; 2000 Jul; 180(1):1-5. PubMed ID: 11036130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET scans superior to CT for detection of colon cancer spread.
    Oncology (Williston Park); 2003 Sep; 17(9):1224, 1293. PubMed ID: 14758809
    [No Abstract]   [Full Text] [Related]  

  • 5. [18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.
    Kim S; Chung JK; Kang SB; Kim MH; Jeong JM; Lee DS; Lee MC
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):196-201. PubMed ID: 15129701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules.
    Zhuang H; Hickeson M; Chacko TK; Duarte PS; Nakhoda KZ; Feng Q; Alavi A
    Clin Nucl Med; 2002 Sep; 27(9):628-32. PubMed ID: 12192279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
    Metser U; You J; McSweeney S; Freeman M; Hendler A
    AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 FDG PET demonstration of a thyroid metastasis in a patient with colon cancer.
    Iguchi T; Matsuoka J; Sato S; Okumura Y; Omori M; Mifune H; Akaki S; Kanazawa S
    Clin Nucl Med; 2007 May; 32(5):361-2. PubMed ID: 17452862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
    Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
    Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer.
    Gallagher DJ; Libby DM; Kemeny N
    Clin Colorectal Cancer; 2009 Jul; 8(3):172-4. PubMed ID: 19632934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic kidney mimicking recurrent colon cancer on FDG positron emission tomographic imaging.
    Bhargava P; Zhuang H; Hickeson M; Alavi A
    Clin Nucl Med; 2002 Aug; 27(8):602-3. PubMed ID: 12170012
    [No Abstract]   [Full Text] [Related]  

  • 13. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET).
    Flamen P; Hoekstra OS; Homans F; Van Cutsem E; Maes A; Stroobants S; Peeters M; Penninckx F; Filez L; Bleichrodt RP; Mortelmans L
    Eur J Cancer; 2001 May; 37(7):862-9. PubMed ID: 11313174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.
    Drenth JP; Nagengast FM; Oyen WJ
    Eur J Nucl Med; 2001 Dec; 28(12):1766-9. PubMed ID: 11734913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers.
    Odalovic S; Stojiljkovic M; Sobic-Saranovic D; Pandurevic S; Brajkovic L; Milosevic I; Grozdic-Milojevic I; Artiko V
    Neoplasma; 2017; 64(6):954-961. PubMed ID: 28895416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.
    Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC
    Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
    Gade M; Kubik M; Fisker RV; Thorlacius-Ussing O; Petersen LJ
    Cancer Imaging; 2015 Aug; 15(1):11. PubMed ID: 26263901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.
    Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH
    Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.